The results showed that ELTD1 was overexpressed in the glioma cell line (H4, A-172, U-138MG, LN-18, U-87MG and U-87MG) compared with its expression in the human brain gliocyte cell line (HA and HM) (Supplement 4). This evidence concerns the gene ADGRL4 and central nervous system cancer.